Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Reexamination Certificate
2005-02-22
2005-02-22
Badio, Barbara P. (Department: 1616)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
Reexamination Certificate
active
06858593
ABSTRACT:
There is provided a crystalline chemical composition comprising a compound of formula (I)in which the crystal lattice is stabilized by the presence of a guest molecule, characterized in the crystalline composition is of space group P212121having unit cell dimensions of about 7.6±0.6 Å, 12.7±0.7 Å, and 33±3 Å when determined at 120 K.
REFERENCES:
patent: 3067197 (1962-12-01), Agnello et al.
patent: 3639434 (1972-02-01), Oxley et al.
patent: 3828080 (1974-08-01), May et al.
patent: 3856828 (1974-12-01), Phillips et al.
patent: 3981894 (1976-09-01), Phillips et al.
patent: 3989686 (1976-11-01), Phillips et al.
patent: 4093721 (1978-06-01), Phillips et al.
patent: 4187301 (1980-02-01), Edwards
patent: 4188385 (1980-02-01), Edwards
patent: 4198403 (1980-04-01), Alvarez
patent: 4261984 (1981-04-01), Alvarez
patent: 4263289 (1981-04-01), Edwards
patent: 4267173 (1981-05-01), Draper
patent: 4285937 (1981-08-01), Kalvoda
patent: 4310466 (1982-01-01), Edwards
patent: 4335121 (1982-06-01), Phillipps et al.
patent: 4377575 (1983-03-01), Phillips et al.
patent: 4472393 (1984-09-01), Shapiro
patent: 4607028 (1986-08-01), Schmidlin
patent: 4710495 (1987-12-01), Bodor
patent: 4861765 (1989-08-01), Jouveinal
patent: 4992474 (1991-02-01), Skidmore et al.
patent: 4994439 (1991-02-01), Longenecker et al.
patent: 4996335 (1991-02-01), Bodor
patent: 5250293 (1993-10-01), Gleich
patent: 5420120 (1995-05-01), Boltralik
patent: 5658549 (1997-08-01), Akehurst et al.
patent: 5707984 (1998-01-01), Tjoeng et al.
patent: 5837699 (1998-11-01), Sequeira et al.
patent: 5849265 (1998-12-01), Li-Bovet et al.
patent: 5889015 (1999-03-01), Sequeira et al.
patent: 5919776 (1999-07-01), Hagmann et al.
patent: 5972920 (1999-10-01), Seidel
patent: 5981517 (1999-11-01), Bodor
patent: 6057307 (2000-05-01), Sequeira et al.
patent: 6127353 (2000-10-01), Yuen et al.
patent: 6136294 (2000-10-01), Adjei et al.
patent: 6197761 (2001-03-01), Biggadike et al.
patent: 6261539 (2001-07-01), Adjei et al.
patent: 6395300 (2002-05-01), Straub et al.
patent: 2338693 (1975-02-01), None
patent: 2538569 (1977-03-01), None
patent: 0004773 (1979-10-01), None
patent: 0057401 (1982-08-01), None
patent: 0135478 (1985-03-01), None
patent: 0179583 (1986-04-01), None
patent: 0416951 (1991-03-01), None
patent: 0418716 (1991-03-01), None
patent: 0521455 (1993-01-01), None
patent: 0640616 (1995-03-01), None
patent: 0646593 (1995-04-01), None
patent: 580494 (1986-10-01), None
patent: 1384372 (1975-02-01), None
patent: 1438940 (1976-06-01), None
patent: 1517278 (1978-07-01), None
patent: 2079755 (1982-01-01), None
patent: 2140800 (1984-12-01), None
patent: 109656 (1998-02-01), None
patent: 04208267 (1992-07-01), None
patent: 9214472 (1992-09-01), None
patent: 9421229 (1994-09-01), None
patent: 9531964 (1995-11-01), None
patent: 9619199 (1996-06-01), None
patent: 9705136 (1997-02-01), None
patent: 9715298 (1997-05-01), None
patent: 9724365 (1997-07-01), None
patent: 9746243 (1997-12-01), None
patent: 9817676 (1998-04-01), None
patent: 9834596 (1998-08-01), None
patent: 9843630 (1998-10-01), None
patent: 9901467 (1999-01-01), None
patent: 9925359 (1999-05-01), None
patent: 9932089 (1999-07-01), None
patent: 0016814 (2000-03-01), None
patent: 0115744 (2000-03-01), None
patent: 0033892 (2000-06-01), None
patent: 0038811 (2000-07-01), None
patent: 0057401 (2000-08-01), None
patent: 0104118 (2001-01-01), None
patent: 0120331 (2001-03-01), None
patent: 0154664 (2001-08-01), None
patent: 0162722 (2001-08-01), None
patent: 0176745 (2001-10-01), None
patent: 0178736 (2001-10-01), None
patent: 0178739 (2001-10-01), None
patent: 0178741 (2001-10-01), None
patent: 0200199 (2002-01-01), None
patent: 0200679 (2002-01-01), None
patent: 02007767 (2002-01-01), None
patent: 02008243 (2002-01-01), None
patent: 02012265 (2002-02-01), None
patent: 02012266 (2002-02-01), None
patent: 02013858 (2002-02-01), None
patent: 0226723 (2002-04-01), None
patent: 02053186 (2002-07-01), None
patent: 02066422 (2002-08-01), None
patent: 02070490 (2002-09-01), None
patent: 02076933 (2002-10-01), None
patent: 02085296 (2002-10-01), None
patent: 02088167 (2002-11-01), None
patent: 02100879 (2002-12-01), None
patent: 03013427 (2003-02-01), None
patent: 03033000 (2003-04-01), None
patent: 03035668 (2003-05-01), None
patent: 03040691 (2003-05-01), None
patent: 03042229 (2003-05-01), None
patent: 03042230 (2003-05-01), None
patent: 872389 (1987-04-01), None
U.S. Appl. No. 09/958,050, filed on Oct. 2, 2001.
U.S. Appl. No. 10/066,836, filed on Feb. 4, 2002.
U.S. Appl. No. 10/066,951, filed on Feb. 4, 2002.
U.S. Appl. No. 10/068,964, filed on Feb. 4, 2002.
U.S. Appl. No. 10/067,010, filed on Feb. 4, 2002.
U.S. Appl. No. 10/067,020, filed on Feb. 4, 2002.
U.S. Appl. No. 10/241,658, filed on Sep. 11, 2002.
U.S. Appl. No. 10/281,735, filed on Oct. 28, 2002.
Phillipps, G.H., et al., “Synthesis and Structure-Activity Relationships in a series of Antiinflammatory Corticosteroid Analogues, Halomethyl Androstane-17β-carbothioates and- 17β-carboselenoates,” Journal of Medicinal Chemistry 1994, 37, 3717-3729.
Janette M. Mahoney et al., “Drug effects on the neovascularization response to silver nitrate cauterization of the rat cornea” Current Eye Research, vol. 4, No. 5, 1985, pp. 531-535.
Richard A. Kanley et al., “An Automated Column-Switching HPLC Method for Analyzing Active and Excipient Materials in Both Cream and Ointment Formulations,” Drug Development and Industrial Pharmacy, vol. 11, (9&10), 1985, pp. 1781-1796.
R. Woodford et al., “Activity and bioavailability of a new steroid (Timobasone acetate) in cream and ointment compared with Lidex and Dermovale creams and ointments and Betnovate cream” Int'l Journal of Pharmaceutics, vol. 26 (1985) pp. 145-155.
Denis J. Kertasz et al., “Thiol Esters from Steroid 17β-Carboxylic Acids: Carboxylate Activation and Internal Participation by 17 α-Acytates” J. Org. Chem., vol. 51, 1986, pp. 2315-2328.
Popper, T.L., et al., “Structure-Activity Relationship of a series of novel topical corticosteroids”, Journal of Steroid Biochemistry 1987, 837 -843.
John T. H. Ong et al., “Micellar Solubilization of Timobesone Acetate in Aqueous and Aqueous Propylene Glycol Solutions of Nonionic Surfactants”, Pharmaceutical Research, vol. 5, No. 11, 1988, pp. 704-708.
John T. H. Ong et al., Intrinsic Potencies of Novel Thiol Ester Corticosteroids RS-85095 and RS-21314 as Compared With Clobetasol 17-Propionate and Fluocinonids Arch Dermatol, vol. 125, Dec. 1989, pp. 1662-1665.
Isogal, Mitsutaka, et al., “Binding affinities of Mometasone Furoate and related compounds including its Metabolites for the Glucocorticoid Receptor of Rat Skin Tissue” J. Steroid Biochem. Mol. Biol. 1993, 141-145.
S.J. Lane et al., “Evaluation of a New Capillary Electrochromatography/Mass Spectrometry Interface Using Short Columns and High Field Strengths for Rapid and Efficient Analyses,” Rapid Communications in Mass Spectrometry, vol. 10, 1996, pp. 733-736.
Franklin I. Algbirhio et al., “Automated Radiosynthesis of No-carrier-added [S-fluoromethyl-18F]Fluticasone Propionate as a Radiotracer for Lung Deposition Studies with PET” Journal of Labelled Compounds and Radiopharmaceuticals, vol. 39, No. 7, 1997, pp. 569-584.
Nisha Mistry et al., “Characterization of impurities in bulk drug batches of fluticasone propionate using directly coupled HPLC-NMR spectroscopy and HPLC-MS,” Journal of Pharmaceutical and Biomedical Analysis vol. 16, 1997, pp. 697-705.
Nisha Mistry et al., Impurity profiling in bulk pharmaceutical batches using 19F NMR spectroscopy and distinction between monomeric and dimeric impurities by NMR-based diffusion measurements, Journal of Pharmaceutical and Biomedical Analysis, vol. 19, 1999, pp. 511-517.
N. Smith et al., “Comparison of the electrosmotic flow profiles and selectivity of stationary phases used in capillary electromatography,” Journal of Chromatogra
Biggadike Keith
Chetina Olga
Coote Steven John
Craig Andrew
Jacewicz Victor
Badio Barbara P.
Riek James P.
Smithkline Beecham Corporation
LandOfFree
Anti-inflammatory androstane derivative compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-inflammatory androstane derivative compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-inflammatory androstane derivative compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3456999